| SGMT Stock | | | 5.69 0.15 2.71% |
Founder
Urs Greber is CoFounder of Sagimet Biosciences Series
| Address | 155 Bovet Road, San Mateo, CA, United States, 94402 |
| Phone | 650 561 8600 |
| Web | https://www.sagimet.com |
Sagimet Biosciences Management Efficiency
The company has return on total asset
(ROA) of
(0.2154) % which means that it has lost $0.2154 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
(0.2932) %, meaning that it created substantial loss on money invested by shareholders. Sagimet Biosciences' management efficiency ratios could be used to measure how well Sagimet Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.
Return On Tangible Assets is likely to drop to -0.3 in 2024.
Return On Capital Employed is likely to drop to -0.35 in 2024.
Total Current Liabilities is likely to drop to about 3.8
M in 2024.
Liabilities And Stockholders Equity is likely to drop to about 59.2
M in 2024
Sagimet Biosciences Series (SGMT) is traded on NASDAQ Exchange in USA. It is located in 155 Bovet Road, San Mateo, CA, United States, 94402 and employs 8 people. Sagimet Biosciences is listed under Biotechnology category by Fama And French industry classification.
Management Performance
Sagimet Biosciences Leadership Team
Elected by the shareholders, the Sagimet Biosciences' board of directors comprises two types of representatives: Sagimet Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sagimet. The board's role is to monitor Sagimet Biosciences' management team and ensure that shareholders' interests are well served. Sagimet Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sagimet Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, CFO Officer | |
| Joe Oriti, Interim Officer | |
| Elizabeth JD, General Officer | |
| David Happel, President CEO | |
| Lucas Pelkmans, CoFounder | |
| George Kemble, Executive Board | |
| Urs Greber, CoFounder | |
| Robert DUrso, Senior Products | |
| JD Esq, General Officer | |
| DPhil MD, Chief Officer | |
| Thierry Chauche, CFO Officer | |
| Marie OFarrell, Senior Development | |
Sagimet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sagimet Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Sagimet Stock Analysis
When running Sagimet Biosciences' price analysis, check to
measure Sagimet Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sagimet Biosciences is operating at the current time. Most of Sagimet Biosciences' value examination focuses on studying past and present price action to
predict the probability of Sagimet Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sagimet Biosciences' price. Additionally, you may evaluate how the addition of Sagimet Biosciences to your portfolios can decrease your overall portfolio volatility.